LYCOS RETRIEVER Beta Retriever Home  |  What is Lycos Retriever?   
Gene: Genes
built 291 days ago
Retriever  > Arts  > Music  > Styles
Retriever  > Recreation  > Collecting  > Toys  > Gene
Gene Simmons Family Jewels is returning to A&E for a third season. The reality series stars KISS rock star Gene Simmons and his unconventional family. Season three of Gene Simmons Family Jewels will kick off with back-to-back episodes and will run for twenty-four episodes.
Source:
If you asked people to name the top five musicians in Bluegrass in Canada, Gene Bretecher’s name would be on the list. Born in Manitoba, Gene began playing bluegrass in the early 60’s. Gene once described the bluegrass as “acoustic folk music in overdrive.” Not surprisingly, this is a description of his own banjo and guitar-playing style.
Through the years of researching genetics and a focus breeding program, Gene has written several excellent articles on genetics and breeding for color. Learn pertinent information that will benefit your breeding program.
Genes often contain regions that do not encode products, but regulate gene expression. The genes of eukaryotic organisms can contain regions called introns that are removed from the messenger RNA in a process called splicing. The regions encoding gene products are called exons. In eukaryotes, a single gene can encode multiple proteins, which are produced through the creation of different arrangements of exons through alternative splicing. In prokaryotes (bacteria and archaea), introns are less common and genes often contain a single uninterrupted stretch of DNA, called a cistron, that codes for a product. Prokaryotic genes are often arranged in groups called operons with promoter and operator sequences that regulate transcription of a single long RNA.
This press release contains certain forward-looking statements relating to Genetronics' plans to develop its electroporation drug and gene delivery technology and to maximize shareholder value. Actual events or results may differ from Genetronics' expectations as a result of a number of factors, including the uncertainties inherent in clinical trials and product development programs, evaluation of potential opportunities, the level of corporate expenditures, the assessment of Genetronics' technology by potential corporate partners, and capital market conditions, and others set forth in the Genetronics Annual Report, on Form 10-K for the 12-month period ending December 31, 2003, and the Form 10-Q for the 3-month period ending March 31, 2004, and other regulatory filings. There can be no assurance that any product in the Genetronics product pipeline will be successfully developed or manufactured, or that final results of human pilot studies or clinical studies will be supportive of regulatory approvals required to market Licensed Products. The American Stock Exchange has not reviewed and do not accept responsibility for the adequacy or accuracy of this release.
Gene targeting is commonly referred to techniques for altering or disrupting mouse genes and provides the mouse models for studying the roles of individual genes in embryonic development, human disorders, aging and diseases. The mouse models, where one or more of its genes are deactivated or made inoperable, are called knockout mice. Since the first reports in which homologous recombination in embryonic stem cells was used to generate gene-targeted mice,[19] gene targeting has proven to be a powerful means of precisely manipulating the mammalian genome, producing at least ten thousand mutant mouse strains and it is now possible to introduce mutations that can be activated at specific time points, or in specific cells or organs, both during development and in the adult animal.[20][21]
SEARCH
MORE ABOUT